Blinklab Fpo has released a press release.
Appointment of Managing Director and Board Changes
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Blinklab
- Pilot Study Confirms High Diagnostic Accuracy & Readiness
- 2025 Annual Report & Appendix 4E
- US Ethics Approval Received for the Main Phase of FDA510(k)
- Response to ASX Price and Volume Query
- Successful Placement of A$7.66M to Underpin Growth Strategy
Later from Blinklab
- High-Profile Journal Publication Validates BB1 Technology
- Quarterly Activities/Appendix 4C Cash Flow Report
- Half Yearly Report and Accounts
- Clinical Trial Network for Pivotal FDA Study Complete
- Trading Halt
Follow Blinklab into a list and get an email when it puts out news.
Follow Blinklab